Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt

2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt is listed in the pharmaceutical impurity collection. Its represented structure has formula C8H15F3N2O5 and a calculated molecular weight of 276.21 g/mol.

2D chemical structure

H 2 N O O H N H 2 H O O H O F F F ( R ) ( R ) ( S )

Chemical identity

Catalog name
2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt
Common name
2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt
Chemical name
Not available
CAS
Not available
SMILES
NC[C@H]1OC(O)[C@H](N)C[C@@H]1O.O=C(O)C(F)(F)F
InChI
InChI=1S/C6H14N2O3.C2HF3O2/c7-2-5-4(9)1-3(8)6(10)11-5;3-2(4,5)1(6)7/h3-6,9-10H,1-2,7-8H2;(H,6,7)/t3-,4+,5-,6?;/m1./s1
InChIKey
QUSDFBAAHZCVSL-CYVAYKCTSA-N
Associated API
Tobramycin

Record ID: Ae761c5967e65

Computed properties

C8H15F3N2O5 Molecular formula
276.211 g/molMolecular weight
276.0933 DaMonoisotopic exact mass
139.03 ŲTopological polar surface area
-1.6261 Calculated LogP (Wildman–Crippen)
52.2242 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
5 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 2 disconnected components. Calculations retain all represented components. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 4 8 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight276.21137.05
Calculated LogP (Wildman–Crippen)-1.62615.11
Topological polar surface area139.0386.89
Hydrogen-bond acceptors675.83
Hydrogen-bond donors594.13
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC8H15F3N2O5dimensionless
Molecular weight276.211g/mol
Monoisotopic exact mass276.0933Da
Topological polar surface area139.03Ų
Calculated LogP (Wildman–Crippen)-1.6261dimensionless
Molar refractivity (Wildman–Crippen)52.2242cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors5count
Rotatable bonds (strict)1count
Heavy atoms18count
Heteroatoms10count
Rings1count
Aromatic rings0count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.875fraction
Formal charge0e
Disconnected components2count
Isotopically specified atoms0count
Potential atom stereocenters4count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area100.128Ų
Valence electrons108count
Radical electrons0count
Bertz complexity275.9483index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt

Qualification and safety assessment of 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt

Explore toxicological qualification of 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt and ICH M7 mutagenic impurity assessment of 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt and acceptable intake and limit justification for 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt

Explore Altox services and software through the Altox Pharma-Hub.